Safety Outcomes from a Long-Term, Prospective Study of Sertraline Use in Children and Adolescents: The Sertraline Pediatric Registry for the Evaluation of Safety.

Saved in:
Bibliographic Details
Title: Safety Outcomes from a Long-Term, Prospective Study of Sertraline Use in Children and Adolescents: The Sertraline Pediatric Registry for the Evaluation of Safety.
Authors: Ramaker S; Pfizer Research and Development, Pfizer, Collegeville, Pennsylvania, USA., Kolitsopoulos F; Worldwide Research and Development, Pfizer, New York, New York, USA., Ludwig L; Pfizer Research and Development, Pfizer, Collegeville, Pennsylvania, USA., Compton SN; Duke Clinical Research Institute, Durham, New York, USA., Broderick S; Duke Clinical Research Institute, Durham, New York, USA., Orazem J; Pfizer Research and Development, Pfizer, New York, New York, USA., Bao W; Pfizer Research and Development, Pfizer, New York, New York, USA., Lokhnygina Y; Duke Clinical Research Institute, Durham, New York, USA., Hackley S; Viatris, Canonsburg, Pennsylvania, USA., Chappell P; Pfizer Research and Development, Pfizer, Groton, Connecticut, USA.
Source: Journal of child and adolescent psychopharmacology [J Child Adolesc Psychopharmacol] 2025 Aug; Vol. 35 (6), pp. 326-336. Date of Electronic Publication: 2025 Feb 20.
Publication Type: Journal Article; Observational Study; Multicenter Study
Journal Info: Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 9105358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8992 (Electronic) Linking ISSN: 10445463 NLM ISO Abbreviation: J Child Adolesc Psychopharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-8992
DOI:10.1089/cap.2024.0054